Literature DB >> 6982136

Effect of indomethacin treatment upon actively-induced and transferred experimental allergic encephalomyelitis (EAE) in Lewis rats.

H Ovadia, P Y Paterson.   

Abstract

Daily administration of indomethacin (5 mg/kg) to Lewis rats from day 7 through day 21 following sensitization to guinea-pig spinal cord neural antigen plus Freund's complete adjuvant (FCA) resulted in an aggravation of clinical signs of EAE accompanied by a higher mortality. In contrast, lymph node cells (LNC) from sensitized and drug-treated donor rats showed decreased EAE transfer activity. The in vitro Con A response of LNC from sensitized, indomethacin-treated rats was comparable to those of normal LNC or LNC from sensitized animals only. The spleen cell response of sensitized rats was significantly lower than the response seen in normal animals, but was returned to normal levels in sensitized, indomethacin-treated animals. We believe these observations reflect an indomethacin-mediated diminished accumulation of EAE effector cells within peripheral lymph node tissues together with abrogation of splenic suppressor cell activity by indomethacin-mediated inhibition of prostaglandin (PG) synthesis in Lewis rats sensitized and treated with this drug under the conditions defined.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6982136      PMCID: PMC1536482     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  19 in total

1.  Transfer of allergic encephalomyelitis using splenectomized albino rats.

Authors:  P Y PATERSON; N C DIDAKOW
Journal:  Proc Soc Exp Biol Med       Date:  1961-12

2.  [Negative results following use of indomethacin in treatment of multiple sclerosis].

Authors:  A Niewodniczy; E Poźniak-Patewicz
Journal:  Neurol Neurochir Pol       Date:  1973 Mar-Apr       Impact factor: 1.621

Review 3.  Relevance of fatty acids in multiple sclerosis.

Authors:  J Mertin; C J Meade
Journal:  Br Med Bull       Date:  1977-01       Impact factor: 4.291

4.  Cellular transfer of experimental allergic encephalomyelitis in Lewis rats: effects of different sensitization regimens on in vitro reactivity of donor spleen cells to concanavalin A.

Authors:  H Ovadia; P Y Paterson
Journal:  Cell Immunol       Date:  1981-11-15       Impact factor: 4.868

5.  Prostaglandin precursors and the cell-mediated immune response.

Authors:  J Mertin; A Stackpoole
Journal:  Cell Immunol       Date:  1981-08       Impact factor: 4.868

6.  Induction of suppressor cells in rat spleen: influence of microbial stimulation.

Authors:  J A Mattingly; D D Eardley; J D Kemp; R K Gershon
Journal:  J Immunol       Date:  1979-03       Impact factor: 5.422

7.  Suppression by essential fatty acids of experimental allergic encephalomyelitis is abolished by indomethacin.

Authors:  J Mertin; A Stackpoole
Journal:  Prostaglandins Med       Date:  1978-10

8.  Lymphocyte traffic through antigen-stimulated lymph nodes. II. Role of Prostaglandin E2 as a mediator of cell shutdown.

Authors:  J Hopkins; I McConnell; J D Pearson
Journal:  Immunology       Date:  1981-02       Impact factor: 7.397

9.  Transfer of allergic encephalomyelitis in rats by means of lymph node cells.

Authors:  P Y PATERSON
Journal:  J Exp Med       Date:  1960-01-01       Impact factor: 14.307

10.  Timing of indomethacin in the control of prostaglandins, osteoclasts and bone destruction produced by VX2 carcinoma in rabbits.

Authors:  C S Galasko; R Rawlins; A Bennett
Journal:  Br J Cancer       Date:  1979-09       Impact factor: 7.640

View more
  5 in total

1.  Cyclooxygenase expression and prostaglandin levels in central nervous system tissues during the course of chronic relapsing experimental autoimmune encephalomyelitis (EAE).

Authors:  Samir S Ayoub; Elizabeth G Wood; Sabih-Ul Hassan; Christopher Bolton
Journal:  Inflamm Res       Date:  2011-06-12       Impact factor: 4.575

2.  Dual roles of PGE2-EP4 signaling in mouse experimental autoimmune encephalomyelitis.

Authors:  Yoshiyasu Esaki; Youxian Li; Daiji Sakata; Chengcan Yao; Eri Segi-Nishida; Toshiyuki Matsuoka; Kazuhiko Fukuda; Shuh Narumiya
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-21       Impact factor: 11.205

3.  The protective effects of omega-6 fatty acids in experimental autoimmune encephalomyelitis (EAE) in relation to transforming growth factor-beta 1 (TGF-beta1) up-regulation and increased prostaglandin E2 (PGE2) production.

Authors:  L S Harbige; L Layward; M M Morris-Downes; D C Dumonde; S Amor
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

4.  Fatal neurological disease in scrapie-infected mice induced for experimental autoimmune encephalomyelitis.

Authors:  Yael Friedman-Levi; Haim Ovadia; Romana Hoftberger; Ofira Einstein; Oded Abramsky; Herbert Budka; Ruth Gabizon
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

5.  Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain.

Authors:  S J Khoury; W W Hancock; H L Weiner
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.